跳至主要内容
临床试验/NCT05128656
NCT05128656撤回不适用

Kinetic of Humoral Immune Response of Asymptomatic Nursing Homes (EHPAD) Employees Infected With Severe Acute Respiratory Syndrome Coronavirus : a Case Control Study

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家开始时间: 2022年6月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
rate of positive IgG serology

研究概览

简要总结

The investigators performed in April 2020, a screening campaign of asymptomatic staff working in elderly nursing homes in Paris France (EHPAD), where the virus had been circulating actively in March and April 2020. Among 241 employees tested in four nursing homes, 32 (13.2%) were asymptomatic carriers of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2).

Few data are available concerning the humoral immune response of asymptomatic carriers, the elicitation and duration of neutralizing antibodies and the duration of protection.

The purpose of the study is to determine whether these asymptomatic persons develop a humoral immune response, whether this immune response is durable and whether it is protective against the risk of reinfection

详细描述

The investigators performed in April 2020, a screening campaign of asymptomatic staff working in elderly nursing homes in Paris, France, where the virus had been circulating actively in March and April 2020. Among 241 employees tested in four nursing homes, 32 (13.2%) were asymptomatic carriers of SARS-Cov-2.

Few data are available concerning the humoral immune response of asymptomatic carriers, the elicitation and duration of neutralizing antibodies and the duration of protection.

The main objective of this study is to describe the SARS-Cov-2 asymptomatic employees with positive immunoglobulin G (igG) serology at month 1-2 post infection.

Secondary objectives are

  • To describe the proportion of asymptomatic persons with SARS-Cov-2 antibodies month 3 and 6 post infection
  • To compare the proportion of persons with SARS-Cov-2 antibodies between asymptomatic and asymptomatic carriers at M1-2 post infection, M3 and M6 post infection
  • To determine the factors associated with the appearance of antibodies ( viral load, age, sex, previous history, habitus..)
  • To study the neutralizing capacities and immune-profiling of SARS-Cov-2 antibodies in vitro
  • To evaluate the occurrence of Coronavirus Disease 2019 (COVID-19) reinfections in asymptomatic carriers during the second wave.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Common inclusion criteria:
  • •Health care employees working in the EHPAD who consulted in the Hotel Dieu Hospital
  • •Affiliated with a health insurance
  • •Informed information and consent
  • •Inclusion Criteria for Cases (asymptomatic COVID-19 patients) :
  • •Health care workers screened SARS-Cov-2 positive for NASopharyngeal swaths during screening campaigns for EHPAD staff.
  • •Having carried out a follow-up serology (M1 and M2) within the Hotel Dieu.
  • •Having never developed symptoms of COVID-19 or have developed some symptoms undetected before screening: fever, transient fatigue, rhinorrhea, symptoms that may be mistaken for a common winter cold (no respiratory symptoms or prolonged fever)
  • •Inclusion criteria for controls (symptomatic COVID-19 patients) :
  • •Health care workers tested positive for polymerase chain reaction assay (PCR) SARS-Cov-2 during screening campaigns for EHPAD staff at the Hotel Dieu.
  • •Having carried out a follow-up serology (M1 and M2) within the Hotel Dieu.
  • •COVID-19 symptoms defined by:
  • •At least two major signs of COVID-19 among: > fever, cough, chest tightness, bilateral pneumonia, anosmia, loss of taste.
  • •or a major sign and three minor signs among: headache, severe fatigue, diarrhea, odynophagia, rhinorrhea, suggestive skin signs.
  • •It is part of the database of the virology department of Cochin Hospital (in case of failure to recruit health care workers in the EHPADs).

排除标准

  • •Refuse to participate or inability to obtain informed consent.
  • •under guardianship, curators
  • •negative SARS-COV-2 PCR
  • •Pregnancy

研究组 & 干预措施

Cases

Other

SARS-Cov-2 asymptomatic nursing homes employees

干预措施: serology (Other)

Controls

Other

cohort of patients with a symptomatic COVID-19, preferably recruited in nursing homes or in case of difficulties in the virology service of COCHIN Hospital.

干预措施: serology (Other)

结局指标

主要结局

rate of positive IgG serology

时间窗: month 1-2 post infection

positive IgG (Immunoglobulin G) SARS-Cov-2 serology after infection of asymptomatic employees

次要结局

  • rate of positive IgG serology(month 3-6 post infection)
  • questionnaire(month 1-2-3 and 6 post infection)
  • rate of positive immunoglobulin M (IgM) serology(month 1-2-3 and 6 post infection)
  • rate of neutralizing antibodies(month 1-2-3 and 6 post infection)
  • re infection(through study completion, an average of 8 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验